However, we reported that radiation combined with MEK/ERK inhibitor treatment in in vivo and in vitro system of rhabdomyosarcoma and prostate cancer cells works better owing to MEK/ERK inhibitor-mediated down regulation of components of DNA repair machinery [107,112]. Here, MAPK1 is linked to prostate cancer.